Grant: Fellowship - PA: CIHR/Rx&D - CAMO Research Program
University of Calgary
$35,000.00
Nuclear magnetic resonance spectroscopy of biofluids: Identification of oncologic biomarkers
EF 2008-09
Résumé
Cancer cells are, by their very nature, highly metabolic cells that are turned 'on' in their attempt to grow and spread. The end products of a cancer cell's metabolism are small molecules called metabolites, and these are excreted in biofluids such as serum, urine, and saliva. We hypothesize that by identifying these metabolites we may be able to detect cancer while it is still small and curable, or that by monitoring metabolites during treatment we may be able to predict which patients will benefit from the treatment, and which patients should change treatment. The advantage of measuring metabolites is again that they are secreted into blood, urine, or even saliva, all easily obtained from patients without discomfort or great expense. Nuclear magnetic resonance (NMR) is a special technique used by chemists that can identify metabolites in blood, urine, and saliva. We will collect blood, urine, and saliva from patients with cancer and compare metabolites to samples taken from patients without cancer - our hypothesis is that there will be a difference that can be used in the future to detect cancer. We will also take blood, urine, and saliva from patients at different times during treatment for cancer to see if there are any metabolites that help us predict which patients will respond to treatment.
Programme
Fellowship - PA: CIHR/Rx&D - CAMO Research Program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
178341
Name
Molckovsky Andrea
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Medical Oncologists (Ottawa)
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Nuclear magnetic resonance spectroscopy of biofluids: Identification of oncologic biomarkers
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$35,000
Cihrequipment2
$0
Programname2
Fellowship - PA: CIHR/Rx&D - CAMO Research Program
Keyworddelim
Biomarkers; Chemometrics; Chemotherapy; Human Subjects; Medical Oncology; Metabolomics; Nuclear Magnetic Resonance
Abstract
Cancer cells are, by their very nature, highly metabolic cells that are turned 'on' in their attempt to grow and spread. The end products of a cancer cell's metabolism are small molecules called metabolites, and these are excreted in biofluids such as serum, urine, and saliva. We hypothesize that by identifying these metabolites we may be able to detect cancer while it is still small and curable, or that by monitoring metabolites during treatment we may be able to predict which patients will benefit from the treatment, and which patients should change treatment. The advantage of measuring metabolites is again that they are secreted into blood, urine, or even saliva, all easily obtained from patients without discomfort or great expense. Nuclear magnetic resonance (NMR) is a special technique used by chemists that can identify metabolites in blood, urine, and saliva. We will collect blood, urine, and saliva from patients with cancer and compare metabolites to samples taken from patients without cancer - our hypothesis is that there will be a difference that can be used in the future to detect cancer. We will also take blood, urine, and saliva from patients at different times during treatment for cancer to see if there are any metabolites that help us predict which patients will respond to treatment.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Molckovsky, Andrea
Approvedterm
1 an 0 mois
Cihrcontribution2
Patient Oriented Research~ $35,000~ $0~